𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The glioblastoma-derived t cell suppressor factor/ transforming growth factor-β2 inhibits t cell growth without affecting the interaction of interleukin 2 with its receptor

✍ Scribed by Christine Siepl; Stefan Bodmer; Karl Frel; H. Robson MacDonald; Rainer De Martin; Erhard Hofer; Adriano Fontana

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
663 KB
Volume
18
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The glioblastoma-derived T-cell suppress
The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cells
✍ Maria C. Kuppner; Marie-France Hamou; Stefan Bodmer; Adriano Fontana; Nicolas De 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 705 KB

Glioblastoma cells release factors (G-TsF) which inhibit T-cell proliferation. The G-TsF is a novel member of the transforming growth factor beta family and is identical to TGF beta 2. The effect of G-TsF and TGF beta 2 on the induction of LAK cell activity was investigated by culturing PBL obtained

T helper type 1 development of naive CD4
T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β
✍ Edgar Schmitt; Petra Hoehn; Christoph Huels; Sigrid Goedert; Norbert Palm; Erwin 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

## T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin42 and interferon-y and is inhibited by transforming growth factor+* Institut fur Immunologie, Maim It was observed in vitro and in vivo that both interferon (1FN)y and interleukin (1L)-12 can promote

Interaction of epidermal growth factor w
Interaction of epidermal growth factor with initiators and complete carcinogens in the C3H10T1/2 cell culture System
✍ Harvey R. Herschman; David Brankow 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

Unlike 12-0-tetradecanoylphorbol-13-acetate, epidermal growth factor (EGF) could not promote the appearance of type 111 foci from initiated C3HIOT1/2 cells. At appropriate concentrations, EGF induced the formation of type I1 colonies in the absence of any initiator. At higher concentrations, EGF su

ZD1839 (Iressa), a novel epidermal growt
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
✍ Neil G. Anderson; Tawhid Ahmad; Kai Chan; Richard Dobson; Nigel J. Bundred 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB 👁 1 views

Overexpression of the growth factor receptors EGFR and erbB2 occurs frequently in several human cancers and is associated with aggressive tumour behaviour and poor patient prognosis. We have investigated the effects of ZD1839 (Iressa), a novel EGFR tyrosine kinase inhibitor, on the growth, in vitro

Transforming growth factor β1 augments m
Transforming growth factor β1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in swiss 3T3 cells and in murine embryo fibroblasts
✍ Rebecca S. Gilbert; Srinivasa T. Reddy; Dr. Dean A. Kujubu; Weilin Xie; Dr. Stev 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

## Abstract Transforming growth factor‐beta (TGF‐beta), a potent cytokine, modulates a wide variety of biological responses. Among its actions, TGF‐beta can augment prostaglandin synthesis in several cell types. Although TGF‐beta alone has no effect on prostaglandin production in Swiss 3T3 cells, w